Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,186	2,025	1,245	1,128	2,581	1,599
Market Cap Growth	56.42%	62.59%	10.35%	-56.28%	61.40%	-12.69%
Enterprise Value	1,989	1,812	1,061	1,121	2,589	1,264
Last Close Price	113.66	107.15	71.42	66.80	99.67	64.17
PE Ratio	-	-	23.88	-	45.18	-
Forward PE	109.86	53.58	35.07	-	-	33.23
PS Ratio	11.68	12.11	9.48	5.75	10.69	9.78
PB Ratio	2.75	2.44	1.78	1.89	3.14	2.25
P/TBV Ratio	5.03	4.42	4.18	8.11	7.85	-
P/FCF Ratio	43.05	21.26	27.04	8.99	36.86	31.90
P/OCF Ratio	41.48	20.86	25.12	8.19	32.76	29.30
PEG Ratio	7.35	3.57	2.34	-	-	1.61
EV/Sales Ratio	10.96	10.84	8.08	5.71	10.72	7.73
EV/EBITDA Ratio	109.52	31.11	22.90	27.11	22.09	18.31
EV/EBIT Ratio	-	78.73	108.04	369.11	39.07	30.77
EV/FCF Ratio	39.04	19.03	23.04	8.93	36.96	25.22
Debt / Equity Ratio	0.01	0.01	0.01	0.15	0.40	0.64
Debt / EBITDA Ratio	0.23	0.12	0.13	2.09	2.74	6.42
Debt / FCF Ratio	0.09	0.08	0.13	0.70	4.63	9.11
Asset Turnover	0.20	0.19	0.17	0.19	0.18	0.11
Inventory Turnover	4.37	1.71	1.88	4.38	3.50	4.20
Quick Ratio	4.46	8.05	12.49	2.50	10.39	4.70
Current Ratio	5.27	8.93	14.15	2.67	11.15	5.00
Return on Equity (ROE)	-16.56%	-0.53%	8.29%	-0.74%	9.98%	0.89%
Return on Assets (ROA)	-1.14%	1.66%	0.79%	0.18%	3.11%	1.80%
Return on Capital (ROIC)	-1.29%	1.86%	0.88%	0.21%	3.58%	1.99%
Return on Capital Employed (ROCE)	-	2.50%	1.30%	0.50%	5.30%	3.30%
Earnings Yield	-6.05%	-0.20%	4.19%	-2.96%	2.21%	-0.19%
FCF Yield	2.32%	4.70%	3.70%	11.12%	2.71%	3.13%
Buyback Yield / Dilution	-4.84%	-3.00%	-5.27%	2.19%	-2.50%	14.84%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q